Live
- Golf: Diksha moves into Top-20 at South African Women’s Open
- KCR lashes out against BJP and Congress for destroying Telangana
- Dairy Science students visited the Milk cooling plant
- Moody feels Pant ahead in keepers’ race for T20 WC squad; Srikkanth picks Rahul over Samson as reserve keeper
- Thanking voters for extending 'unparalleled support' to NDA, PM Modi says second phase 'too good'
- Natural Relief for Menstrual Cramps: Beetroot Juice Recipe
- Asha Worker died in a road accident
- Akshaya Tritiya 2024 Auspicious Hindu Festival on May 10th
- Celebrating World Veterinary Day 2024: Safeguarding Your Pet’s Vision with Expert Tips
- NSG joins CBI in searching residence of Sheikh Shahjahan’s relative
Pharma sector will cross $130-bn mark by 2030
Representational image
Hyderabad is India’s pharmaceutical hub with 214 FDA approved facilities, said vice-president of Dr Reddy’s Laboratories
Hyderabad: Hyderabad, which is known as the pharma hub of India, is home to 214 USFDA approved facilities in the city and as the growth of the pharma market is coming from complex molecules, it will force companies to invest and build future state-of-the art labs, said Dr Reddy’s Laboratories Limited’s official.
Speaking at the ninth edition of B2B pharma expoPharmaLytica 2023 here, Avinash Kumar Talwar, Vice President, Dr Reddy’s Laboratories said that the Indian pharmaceutical industry is valued at around $50 billion and is expected to grow at a CAGR of 10.7 per centtill 2030. The pharmaceutical sector in India is expected to reach $65 billion by 2024, and $130 billion by 2030.
He further said, “We should be proud that in total there are 214 US FDA approved facilities in Hyderabad which is impressive and that is another reason why Hyderabad is known as the Pharma hub of India. As the growth of Pharma market is coming from complex molecules, it will force them to invest and build future state-of-the art labs.”
He further said thatthe demand for sophisticated equipments and instruments to aid in the process of drug discovery, development, analysis and modelling of the compounds will continue to grow at the same pace. There are many small laboratories in Hyderabad and other South Indian cities like Chennai and Bengaluru, he added.
